SEC Form 4 · accession 0001567619-19-006344
Gritstone Oncology, Inc. · GRTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erin Jones
Officer — See Remarks
Period of report
Jan 29, 2019
Accepted (ET)
Mar 6, 2019 · 8:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001656634
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2019 | M | 10,000 | $0.345 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.345 | Jan 29, 2019 | M | 10,000 | D | May 9, 2017 | May 17, 2026 | Common Stock | 10,000 | 47,971 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable with respect to 25% of the total number of shares on May 9, 2017. The remaining shares vest and become exercisable in equal monthly installments over the following 36 months.
Remarks
Executive Vice President, Global Regulatory Affairs and Quality Assurance